Constantino defies Cramer on pharma stocks: Buy

Mad Money host Jim Cramer has not gotten the last word on his recent advice to investors to sell their big pharma stocks. Seeking Alpha contributor Frank Constantino says if investors shift to defensive sectors, big pharma will rise again. So it's worth the wait. His top four picks: Eli Lilly, Bristol-Myers Squibb, Abbott Labs and Johnson & Johnson. Column

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.